Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | +3.25% |
|
+4.96% | +8.55% |
Jun. 25 | Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target | MT |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
Evolution of the average Target Price on Clearside Biomedical, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Clearside Biomedical, Inc.
HC Wainwright | |
Wedbush | |
JonesTrading Institutional Services | |
JMP Securities | |
Needham & Co. | |
Stifel Nicolaus | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- CLSD Stock
- Consensus Clearside Biomedical, Inc.